Skip to search formSkip to main contentSkip to account menu

Chemotherapy Regimen

Known as: cancer pharmacotherapy, neoplasm chemotherapy, chemo 
National Institutes of Health

Related topics

Related topics

15 relations
Antineoplastic AgentsChemotherapy:Prid:Pt:Cancer.XXX:NomCrotoxinPharmacotherapy

Broader (1)

Chemotherapy

Narrower (8)

Chemotherapy Regimen or Agent Combinationchemoprevention of cancerchemosensitization/potentiationcyclophosphamide/losoxantrone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.
Highly Cited
2018
Highly Cited
2018
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
Highly Cited
2014
Highly Cited
2014
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial.
Highly Cited
2011
Highly Cited
2011
Crizotinib in anaplastic large-cell lymphoma.
The anaplastic lymphoma kinase (ALK) inhibitor crizotinib has been shown to induce a response in lung cancers in which ALK is… 
Highly Cited
2005
Highly Cited
2005
Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity.
Low-dose metronomic chemotherapy is a promising therapeutic cancer treatment strategy thought to have an antiangiogenic basis… 
Highly Cited
2000
Highly Cited
2000
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The…
PURPOSE To confirm the promising phase II results of docetaxel monotherapy, this phase III trial was conducted of chemotherapy… 
Highly Cited
1999
Highly Cited
1999
Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C…
PURPOSE Although the benefit from adjuvant chemotherapy has been clearly established in patients with Dukes' C colon cancer, such… 
Highly Cited
1989
Highly Cited
1989
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
During the last decade, the Eastern Cooperative Oncology Group (ECOG) has studied a series of combination chemotherapy regimens… 
Highly Cited
1987
Highly Cited
1987
Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.
One hundred ninety-one patients with advanced epithelial ovarian carcinoma were treated with either a combination of doxorubicin… 
Highly Cited
1982
Highly Cited
1982
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.
Results of second-line chemotherapy regimens against lymphoma have usually been poor. In this study, we used a combination of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)